Conformance in the ePrescribing Ecosystem
Conformance is a mandatory requirement for any product or vendor operating within the ePrescribing ecosystem. By adhering to conformance profiles set by the Australian Digital Health Agency (ADHA), software developers and vendors ensure their solutions meet the functional, technical, and safety standards needed to interact with national digital health systems.
Purpose of Conformance Profiles
Conformance profiles are created and maintained by the ADHA to mitigate risks and establish clear expectations for third-party software that connects with key digital health systems. These profiles define the functional and non-functional requirements for software involved in electronic prescribing, enabling secure and reliable interactions within the ePrescribing ecosystem. Conformance requirements cover aspects like account management, presentation of electronic scripts, and security.
Current Conformance Profiles for Mobile Apps (MA) and Mobile Intermediaries (MI)
-
Conformance Profile 2.3
-
Sunset date set for September 2026.
-
-
Conformance Profile 3.0.1
-
Effective from 1 January 2023.
-
No sunset date set yet
-
-
Conformance Profile 4.0:
-
Release date to be confirmed (TBC)
-
When a new conformance profile is published, implementation does not occur immediately across the ecosystem. Updates first need to be made by systems like the NPDS and ASL to support the new profile. Upstream systems, such as prescribing and dispensing software, may also require updates before Mobile Intermediaries and Mobile Apps can proceed with their own transitions.
Steps in the Conformance Process
To achieve conformance, the following steps are required of vendors and their products:
​
-
Understanding Profile Requirements
-
Review the conformance profile to ensure you understand the functional and non-functional requirements applicable to your software.
-
-
Documenting Evidence
-
Provide detailed documentation demonstrating how your product meets the outlined requirements.
-
-
Observed Conformance Testing
-
Undergo live testing with assessors to validate your solution. This includes demonstrating that your product behaves as intended in accordance with the requirements.
-
-
ADHA Review
-
Final review by ADHA who will then provide approval to go to production and list your app on the
-
Oexa is your trusted assessor
Benefits of Connecting to Oexa's Managed Intermediary
Oexa simplifies the process of achieving and maintaining conformance for vendors connecting to the ePrescribing ecosystem. Here’s how we make it easier for your team:
Proactive Updates
We work hard to keep Oexa’s Mobile Intermediary and Mobile App (Scripty) up to date during new conformance profile rollouts. We ensure our products are updated as soon as upstream systems support the changes. This allows us to address any issues, test new processes, and refine our solutions early.
Streamlined Testing
By ironing out kinks in new conformance profiles ahead of time, we ensure a smoother experience for our partners.
Expert Guidance
Reliable Innovation
Connecting through our established and fully conformant system lets you focus on building your Mobile App or solution without worrying about so many of the technical intricacies of compliance.
By working with Oexa, you gain access to a trusted partner who not only supports your conformance but also helps you maintain a competitive edge within the ePrescribing ecosystem.
Streamline Your ePrescription Workflow
Managed Intermediary integrates seamlessly with your existing ecosystem to streamline your ePrescription workflow. Our platform is designed to simplify the process of managing prescriptions, so you can focus on providing the best care for your customers.